Prove2 study: Treatment of chronic hepatitis C with telaprevir (TVR)in combination with peginterferon-alfa-2a with or without ribavirin, interim analysis results

被引：0
|
作者：
Hezode, Christophe
Ferenci, Peter
Dusheiko, Geoffrey M.
Tran, Albert
Grange, Jean-Didier
Mathurin, Philippe
Schmidt, Wolfgang E.
Diepolder, Helmut
Marcellin, Patrick
Wedemeyer, Heiner
Forestier, Nicole
Mangels, Wendy
Gharakhanian, Shahin
Kauffman, Robert S.
Alam, John
Pawlotsky, Jean-Michel
Zeuzem, Stefan
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A755 / A755
页数：1
相关论文
共 50 条
  • [1] Treatment of chronic hepatitis C with telaprevir (TVR) in combination with peginterferon-alfa-2a with or without ribavirin: Further interim analysis results of the PROVE2 study
    Dusheiko, G. M.
    Hezode, C.
    Pol, S.
    Goeser, T.
    Bronowicki, J. -P.
    Bourliere, M.
    Buggisch, P.
    Serfaty, L.
    Berg, T.
    Couzige, P.
    Benhamou, Y.
    Forestier, N.
    Bengtsson, L.
    Gharakhanian, S.
    Kauffman, R.
    Alam, J.
    Ferenci, P.
    Pawlotsky, J. -M.
    Zeuzem, S.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S26 - S26
  • [2] TELAPREVIR IN COMBINATION WITH PEGINTERFERON-ALFA-2A WITH OR WITHOUT RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C: FINAL RESULTS OF THE PROVE2 STUDY
    Zeuzem, Stefan
    Hezode, Chritophe
    Ferenci, Peter
    Dusheiko, Geoffrey M.
    Alves, Katia
    Bengtsson, Leif
    Gharakhanian, Shahin
    Kauffman, Robert
    Alam, John J.
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2008, 48 (04) : 418A - 419A
  • [3] PROVE2: Phase II study of VX950 (telaprevir) in combination with peginterferon alfa2a with or without ribavirin in subjects with chronic hepatitis C, first interim analysis
    Hezode, Christophe
    Ferenci, Peter
    Dusheiko, Geoffrey M.
    Pol, Stanislas
    Goeser, Tobias
    Bronowicki, Jean-Pierre
    Gharakhanian, Shahin
    Devonish, Desiree
    Kauffman, Robert
    Alam, John
    Pawlotsky, Jean-Michel
    Zeuzem, Stefan
    HEPATOLOGY, 2007, 46 (04) : 268A - 269A
  • [4] A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS
    McHutchison, John G.
    Shiffman, Mitchell L.
    Terrault, Norah
    Manns, Michael P.
    Di Bisceglie, Adrian M.
    Jacobson, Ira M.
    Afdhal, Nezom H.
    Heathcote, E. Jenny
    Zeuzem, Stefan
    Reesink, Hendrik W.
    George, Shelley
    Adda, Nathalie
    Muir, Andrew J.
    HEPATOLOGY, 2008, 48 (04) : 431A - 432A
  • [5] A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS
    Shiffman, Mitchell L.
    Berg, Thomas
    Poordad, F. Fred
    Bronowicki, Jean-Pierre
    Muir, Andrew J.
    Gordon, Stuart C.
    George, Shelley
    Adda, Nathalie
    McHutchison, John G.
    HEPATOLOGY, 2008, 48 (04) : 1135A - 1136A
  • [6] Interim analysis results from a phase 2 study of telaprevir with peginterferon alfa-2a and ribavirin in treatment-naive subjects with hepatitis C
    Jacobson, Ira M.
    Everson, Gregory T.
    Gordon, Stuart C.
    Kauffman, Robert
    McNair, Lindsay
    Muir, Andrew
    McHutchison, John G.
    HEPATOLOGY, 2007, 46 (04) : 315A - 316A
  • [7] VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS
    Di Bisceglie, A. M.
    Nelson, D. R.
    Gane, E.
    Alves, K.
    Koziel, M. J.
    De Souza, C.
    Kieffer, T. L.
    George, S.
    Kauffman, R. S.
    Jacobson, I. M.
    Sulkowski, M. S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S540 - S540
  • [8] Prove1: Results from a phase 2 study of telaprevir with peginterferon alfa-2a and ribavirin in treatment-naive subjects with hepatitis C
    Everson, Gregory T.
    Jacobson, Ira M.
    Gordon, Stuart C.
    McHutchison, John G.
    Kaufman, Robert
    McNair, Lindsay
    Muir, Andrew
    GASTROENTEROLOGY, 2008, 134 (04) : A758 - A758
  • [9] PEGINTERFERON ALFA-2A PLUS RIBAVIRIN COMBINATION TREATMENT IN CHRONIC HEPATITIS C POSTRENAL TRANSPLANT PATIENTS: AN INTERIM ANALYSIS
    Sanai, Faisal M.
    Mousa, Dujanah H.
    Aleid, Hassan
    AlShoail, Ghada
    AlMdani, Abdullah S.
    Al-Ashgar, Hamad I.
    Almeshari, Khalid A.
    Bzeizi, Khalid I.
    HEPATOLOGY, 2010, 52 (04) : 789A - 789A
  • [10] ACTIVITY OF TELAPREVIR MONOTHERAPY OR IN COMBINATION WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE 4 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C210
    Benhamou, Yves
    Moussalli, Joseph
    Ratziu, Vlad
    Lebray, Pascal
    de Backer, Katrien
    Ghys, Anne
    van Heeswijk, Rolf
    Luo, Donghan
    Picchio, Gaston
    Beumont, Maria
    HEPATOLOGY, 2010, 52 (04) : 719A - 720A
12345